Clearmind Medicine (CMND) Interest Expenses (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Interest Expenses of $505000.0 for Q2 2026, up 47812.71% year-over-year from N/an in Q2 2025, and up 900.61% quarter-over-quarter from $50469.0 in Q1 2026.
Clearmind Medicine (CMND) Interest Expenses (2022 - 2026) Analysis & Trends
Clearmind Medicine's Interest Expenses history runs 5 years deep, the most recent figure standing at $505000.0 for Q2 2026.
- In Q2 2026, Interest Expenses rose 47812.71% year-over-year to $505000.0; the TTM figure through Apr 2026 stood at $762333.0 (up 12419.84% YoY), while the FY2025 annual figure was $209196.0, up 3784.07% from the prior year.
- Interest Expenses for Q2 2026 stood at $505000.0, up from $50469.0 in the prior quarter.
- The five-year high for Interest Expenses was $11.1 billion in Q3 2022, with the low at $1.0 in Q1 2024.
- The 5-year median for Interest Expenses is $1723.0 (2023), against an average of $742.8 million.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses tumbled 100.0% in 2023, then soared 127700.0% in 2025.
- Clearmind Medicine's Interest Expenses stood at $11.1 billion in 2022, then sank by 100.0% to $225.0 in 2023, then soared by 549.78% to $1462.0 in 2024, then surged by 13989.74% to $205992.0 in 2025, then surged by 145.16% to $505000.0 in 2026.
- Business Quant data shows CMND's Interest Expenses at $505000.0 in Q2 2026, $50469.0 in Q1 2026, and $205992.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 505,000.00 |
| Apr 30, 2026 | 505,000.00 |
| Jan 31, 2026 | 50,469.00 |
| Jan 31, 2026 | 50,469.00 |
| Oct 31, 2025 | 205,992.00 |
| Oct 31, 2025 | 205,992.00 |
| Jul 31, 2025 | 872.00 |
| Jul 31, 2025 | 872.00 |
| Apr 30, 2025 | 1,054.00 |
| Apr 30, 2025 | 1,054.00 |
| Jan 31, 2025 | 1,278.00 |
| Jan 31, 2025 | 1,278.00 |
| Oct 31, 2024 | 1,462.00 |
| Oct 31, 2024 | 1,462.00 |
| Jul 31, 2024 | 2,295.00 |
| Jul 31, 2024 | 2,295.00 |
| Apr 30, 2024 | 1,628.00 |
| Apr 30, 2024 | 1,628.00 |
| Jan 31, 2024 | 1.00 |
| Jan 31, 2024 | 1.00 |